<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73240</article-id><article-id pub-id-type="doi">10.7554/eLife.73240</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>Fusion of tethered membranes can be driven by Sec18/NSF and Sec17/αSNAP without HOPS</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-83734"><name><surname>Song</surname><given-names>Hongki</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3761-5434</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-8988"><name><surname>Wickner</surname><given-names>William T</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8431-0468</contrib-id><email>Bill.Wickner@Dartmouth.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth</institution><addr-line><named-content content-type="city">Hanover</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Linstedt</surname><given-names>Adam</given-names></name><role>Reviewing Editor</role><aff><institution>Carnegie Mellon University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Pfeffer</surname><given-names>Suzanne R</given-names></name><role>Senior Editor</role><aff><institution>Stanford University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>26</day><month>10</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e73240</elocation-id><history><date date-type="received" iso-8601-date="2021-08-24"><day>24</day><month>08</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-10-25"><day>25</day><month>10</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-08-06"><day>06</day><month>08</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.08.06.455435"/></event></pub-history><permissions><copyright-statement>© 2021, Song and Wickner</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Song and Wickner</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73240-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-73240-figures-v2.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="article-reference" xlink:href="10.7554/eLife.67578"/><abstract><p>Yeast vacuolar membrane fusion has been reconstituted with R, Qa, Qb, and Qc-family SNAREs, Sec17/αSNAP, Sec18/NSF, and the hexameric HOPS complex. HOPS tethers membranes and catalyzes SNARE assembly into RQaQbQc <italic>trans</italic>-complexes which zipper through their SNARE domains to promote fusion. Previously, we demonstrated that Sec17 and Sec18 can bypass the requirement of complete zippering for fusion (Song et al., 2021), but it has been unclear whether this activity of Sec17 and Sec18 is directly coupled to HOPS. HOPS can be replaced for fusion by a synthetic tether when the three Q-SNAREs are pre-assembled. We now report that fusion intermediates with arrested SNARE zippering, formed with a synthetic tether but without HOPS, support Sec17/Sec18-triggered fusion. This zippering-bypass fusion is thus a direct result of Sec17 and Sec18 interactions: with each other, with the platform of partially zippered SNAREs, and with the apposed tethered membranes. As these fusion elements are shared among all exocytic and endocytic traffic, Sec17 and Sec18 may have a general role in directly promoting fusion.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>membrane fusion</kwd><kwd>yeast vacuole</kwd><kwd>SNAREs</kwd><kwd>HOPS</kwd><kwd>Sec17</kwd><kwd>Sec18</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>S. cerevisiae</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35GM118037</award-id><principal-award-recipient><name><surname>Wickner</surname><given-names>William T</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The coordinate activity of Sec17/SNAP and Sec18/NSF for membrane fusion is not limited to systems with homotypic fusion and vacuole protein sorting (HOPS), the lysosomal/vacuolar tethering, and SNARE assembly complex.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Intracellular membrane fusion is catalyzed by families of fusion proteins which are conserved from yeast to humans and among the organelles (<xref ref-type="bibr" rid="bib41">Wickner and Rizo, 2017</xref>). These include Rab-family GTPases, large tethering complexes which bind to Rabs (<xref ref-type="bibr" rid="bib2">Baker and Hughson, 2016</xref>), membrane-anchored SNARE proteins (<xref ref-type="bibr" rid="bib11">Jahn and Scheller, 2006</xref>), and SNARE chaperones of the SM, Sec17/αSNAP, and Sec18/NSF families. SNAREs have conserved SNARE domains of R, Qa, Qb, and Qc sub-families (<xref ref-type="bibr" rid="bib5">Fasshauer et al., 1998</xref>) which assemble into tetrameric RQaQbQc coiled coils <italic>trans-</italic>complexes that bridge membranes before fusion. Each SNARE domain has heptad repeating apolar residues which are buried together in the center of the assembling four-helical coiled coils structure, driving SNARE assembly in an N- to C-direction. This directional assembly, termed ‘zippering’, can provide sufficient energy for fusion (<xref ref-type="bibr" rid="bib33">Sørensen et al., 2006</xref>) and has been thought to be the sole driving force for fusion while other proteins simply catalyze or regulate SNARE assembly.</p><p>We study membrane fusion mechanisms with the vacuoles (lysosomes) of <italic>Saccharomyces cerevisiae</italic>. Yeast vacuole fusion requires proteins of each canonical conserved fusion-protein family, but combines the Rab-effector tethering and the SM functions into the large hexameric HOPS (<underline>ho</underline>motypic fusion and vacuole <underline>p</underline>rotein <underline>s</underline>orting) complex (<xref ref-type="bibr" rid="bib42">Wurmser et al., 2000</xref>; <xref ref-type="bibr" rid="bib25">Seals et al., 2000</xref>; <xref ref-type="bibr" rid="bib36">Stroupe et al., 2006</xref>; <xref ref-type="bibr" rid="bib10">Hickey and Wickner, 2010</xref>). HOPS binds to acidic lipids (<xref ref-type="bibr" rid="bib19">Orr et al., 2015</xref>) and to its Rab Ypt7 on each fusion partner membrane (<xref ref-type="bibr" rid="bib10">Hickey and Wickner, 2010</xref>), activating HOPS (<xref ref-type="bibr" rid="bib34">Torng et al., 2020</xref>) to initiate N- to C-directional assembly among the R, Qa, Qb, and Qc SNAREs. HOPS has direct affinity for the R and Qa SNAREs through its SM subunit (<xref ref-type="bibr" rid="bib1">Baker et al., 2015</xref>) and for the Qb SNARE (<xref ref-type="bibr" rid="bib31">Song et al., 2020</xref>) and Qc SNARE (<xref ref-type="bibr" rid="bib36">Stroupe et al., 2006</xref>) as well. These multiple affinities directly affect the K<sub>m</sub> of SNAREs for SNARE complex assembly (<xref ref-type="bibr" rid="bib45">Zick and Wickner, 2013</xref>). HOPS can assemble intermediates formed from R and any two Q SNAREs which are triggered to undergo rapid fusion by the third Q SNARE (<xref ref-type="bibr" rid="bib31">Song et al., 2020</xref>).</p><p>There has been extensive study, and evolving understanding, of how Sec17/αSNAP and Sec18/NSF promote membrane fusion. ATP hydrolysis by NSF/Sec18 was initially proposed to directly drive fusion (<xref ref-type="bibr" rid="bib16">Malhotra et al., 1988</xref>), while SNAREs mediated the attachment of the NSF fusion engine to membranes (<xref ref-type="bibr" rid="bib28">Söllner et al., 1993b</xref>) via αSNAP/Sec17 (<xref ref-type="bibr" rid="bib40">Whiteheart et al., 1992</xref>). It was subsequently shown that Sec18/NSF and Sec17/αSNAP disassemble SNARE complexes (<xref ref-type="bibr" rid="bib27">Söllner et al., 1993a</xref>), that Sec18/NSF and Sec17/αSNAP act prior to membrane docking (<xref ref-type="bibr" rid="bib17">Mayer et al., 1996</xref>), that NSF/Sec18 and SNAP/Sec17 associate in a specific complex with the SNAREs and induce an conformational change in the SNAREs (<xref ref-type="bibr" rid="bib7">Hanson et al., 1995</xref>; <xref ref-type="bibr" rid="bib8">Hanson et al., 1997</xref>), and that SNARE complexes alone can mediate fusion (<xref ref-type="bibr" rid="bib39">Weber et al., 1998</xref>). These findings led to the concept that all the energy for fusion derives from SNARE zippering (<xref ref-type="bibr" rid="bib39">Weber et al., 1998</xref>; <xref ref-type="bibr" rid="bib33">Sørensen et al., 2006</xref>). Though Sec17/αSNAP will block fusion from spontaneously assembled <italic>trans</italic>-SNARE complexes (<xref ref-type="bibr" rid="bib18">Mima et al., 2008</xref>; <xref ref-type="bibr" rid="bib35">Stepien et al., 2019</xref>), other fusion proteins such as vacuolar HOPS or the synaptic proteins Munc18-1, Munc13-1, complexin-1, and synaptotagmin confer resistance to Sec17/αSNAP and Sec18/NSF (<xref ref-type="bibr" rid="bib18">Mima et al., 2008</xref>; <xref ref-type="bibr" rid="bib21">Prinslow et al., 2019</xref>). Vacuolar SNAREs undergoing HOPS-dependent assembly are resistant to disassembly by Sec17/Sec18 (<xref ref-type="bibr" rid="bib43">Xu et al., 2010</xref>), but Sec17 and Sec18 otherwise keep most SNAREs in a disassembled state; indeed most of the Qa and Qb SNAREs on isolated vacuoles are not together in complex (<xref ref-type="bibr" rid="bib4">Collins et al., 2005</xref>).</p><p>Without Sec17/Sec18, HOPS-assembled <italic>trans</italic>-SNARE complexes require complete zippering to induce fusion, since fusion is arrested by deletion of the C-terminal 21 residues of the Qc SNARE domain (<xref ref-type="bibr" rid="bib23">Schwartz and Merz, 2009</xref>), or the Qa or Qb SNARE domains (<xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>). This fusion arrest is bypassed by adding Sec17 (<xref ref-type="bibr" rid="bib23">Schwartz and Merz, 2009</xref>; <xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>), driven by the apolar N-terminal loop of Sec17 (<xref ref-type="bibr" rid="bib24">Schwartz et al., 2017</xref>). Fusion with only SNAREs is blocked by Sec17/Sec18 (<xref ref-type="bibr" rid="bib18">Mima et al., 2008</xref>). HOPS not only prevents Sec17 inhibition of fusion, but acts synergistically with Sec17/Sec18 for fusion with wild-type SNAREs (<xref ref-type="bibr" rid="bib18">Mima et al., 2008</xref>; <xref ref-type="bibr" rid="bib24">Schwartz et al., 2017</xref>; <xref ref-type="bibr" rid="bib29">Song et al., 2017</xref>). When fusion is blocked by zippering arrest due to deletions from the C-terminus of vacuolar Qc, the block can be bypassed by Sec17, both in vitro and in vivo (<xref ref-type="bibr" rid="bib23">Schwartz and Merz, 2009</xref>; <xref ref-type="bibr" rid="bib24">Schwartz et al., 2017</xref>). A similar block to fusion is also seen with C-terminal truncation of the Qa or Qb SNAREs, singly or in combinations (<xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>). Fusion is restored in each case by Sec17/Sec18 without requiring ATP hydrolysis. Even when both the Qb and Qc SNAREs were C-terminally truncated and the Qa SNARE was mutated to impart polarity to its canonical apolar SNARE domain residues, HOPS-dependent fusion was restored by Sec17/Sec18. Sec17 has direct affinity for HOPS (<xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>) through its Vps33 subunit (<xref ref-type="bibr" rid="bib14">Lobingier et al., 2014</xref>); it has been unclear whether HOPS is needed for Sec17 and Sec18 to engage partially zippered SNAREs and mediate zippering-bypass fusion.</p><p>Sec17 and Sec18 enhance the rate of HOPS-dependent vacuole membrane fusion with all wild-type fusion components (<xref ref-type="bibr" rid="bib18">Mima et al., 2008</xref>; <xref ref-type="bibr" rid="bib46">Zick et al., 2015</xref>; <xref ref-type="bibr" rid="bib29">Song et al., 2017</xref>; <xref ref-type="bibr" rid="bib24">Schwartz et al., 2017</xref>) without requiring ATP hydrolysis (<xref ref-type="bibr" rid="bib46">Zick et al., 2015</xref>; <xref ref-type="bibr" rid="bib29">Song et al., 2017</xref>). A recent study (<xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>) has shown that Sec17, which promotes zippering (<xref ref-type="bibr" rid="bib15">Ma et al., 2016</xref>), will also act through its N-terminal membrane-proximal apolar loop to drive HOPS-dependent fusion even when zippering would be unable to provide any fusion energy. Slow fusion can be driven either by zippering or by the apolar loops of Sec17 which had assembled on a platform of partially zippered <italic>trans</italic>-SNARE complex. Rapid HOPS-dependent fusion requires both SNARE zippering and Sec17 with its apolar loops, as analyzed in vitro and in vivo, where overexpression of Sec17 with an intact N-terminal apolar loop substantially restored the fusion defect caused by Qc SNARE domain truncation (<xref ref-type="bibr" rid="bib24">Schwartz et al., 2017</xref>). Given the two complementary routes of complete SNARE zippering and Sec17 apolar loop insertion, each capable of driving fusion, it is perhaps unsurprising that the precise starting conditions of fusion assays control when the contributions of zippering and of Sec17 are evident. The rate of fusion and its dependence on Sec17 are governed by the fluidity and headgroup composition of the membrane lipids and the initial state of assembly of the SNAREs (<xref ref-type="bibr" rid="bib46">Zick et al., 2015</xref>). Sec17 is required when all the SNAREs are initially disassembled (<xref ref-type="bibr" rid="bib46">Zick et al., 2015</xref>), as found on intact vacuoles (<xref ref-type="bibr" rid="bib4">Collins et al., 2005</xref>) where only a tenth of the Qb SNARE is in complex with Qa (<xref ref-type="bibr" rid="bib4">Collins et al., 2005</xref>), presumably due to continuous <italic>cis</italic>-SNARE disassembly in cells by Sec17/Sec18/ATP. With vacuolar mimic lipid composition and two of the Q SNAREs pre-assembled, fusion is stimulated several-fold by Sec17 and Sec18 (<xref ref-type="bibr" rid="bib29">Song et al., 2017</xref>). When all three Q SNAREs are initially pre-assembled on one membrane, tethering is the only prerequisite for fusion and Sec17/Sec18 is not essential (<xref ref-type="bibr" rid="bib1">Baker et al., 2015</xref>; <xref ref-type="bibr" rid="bib30">Song and Wickner, 2019</xref>). Though little 3Q SNARE complex is found on intact vacuoles (<xref ref-type="bibr" rid="bib4">Collins et al., 2005</xref>), pre-assembly of 3Q-SNARE complex during proteoliposome preparation allows synthetic tethers to support fusion as well as HOPS (<xref ref-type="bibr" rid="bib30">Song and Wickner, 2019</xref>), which is useful for mechanistic studies. Sec17/Sec18 dependence can be restored to fusion reactions where the 3Q SNAREs had been pre-assembled by preventing zippering through the Qc3Δmutation. It has been unclear whether the actions of Sec17 and Sec18 to promote fusion are particular to HOPS-dependent fusion, and thus restricted to the fusion of vacuoles/lysosomes. Our current work, substituting a synthetic protein tether for HOPS, shows that Sec17/Sec18 can also drive HOPS-independent fusion.</p><p>We now exploit a synthetic tether to show that HOPS is not required for Sec17 and Sec18 to drive zippering-bypass fusion. The 4 SNAREs, Sec17/αSNAP, and Sec18/NSF, the fundamental components of the 20s particle (<xref ref-type="bibr" rid="bib44">Zhao et al., 2015</xref>), suffice to drive fusion. As a synthetic tether, we employ the dimeric protein glutathione-<italic>S</italic>-transferase (GST) fused to a PX domain. Dimeric GST-PX binds PI3P in each bilayer to tether membranes (<xref ref-type="bibr" rid="bib30">Song and Wickner, 2019</xref>). When Q SNAREs are pre-assembled into a QaQbQc ternary complex on one fusion partner membrane, tethering by GST-PX supports fusion with membranes bearing the R SNARE without the need for SM function, Sec17 or Sec18 (<xref ref-type="bibr" rid="bib30">Song and Wickner, 2019</xref>). This fusion relies on SNARE zippering, as it is blocked by deletion of the C-terminal region of the Qc SNARE domain, the Qc3Δ mutation. We find that GST-PX tethered membranes bearing R and QaQbQc3Δ SNAREs on fusion partners, unable to completely zipper and fuse because of the shortened Qc SNARE domain, are rescued from this arrested state and will fuse upon addition of Sec17 and Sec18. Thus, the Sec17 and Sec18 fusion functions do not rely on interactions with HOPS, instead acting through their interactions with each other, with tethered membranes, and with a partially zippered <italic>trans</italic>-SNARE binding platform.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>Proteoliposomes were prepared with vacuolar lipids, with membrane-anchored Ypt7, and with either the R- or the 3Q SNAREs. The Qc SNARE was either wild type with its full-length SNARE domain or Qc3Δ which lacks the C-terminal four heptads of its SNARE domain. The Ypt7/R- and Ypt7/3Q-proteoliposomes bore lumenal fusion-reporter fluorescent proteins, either Cy5-labeled streptavidin or biotinylated phycoerythrin (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Proteoliposomes were purified by flotation to remove unincorporated proteins. When these proteoliposomes are mixed, their lumenal fluorescent proteins are separated by at least the thickness of two lipid bilayers, too far for measurable fluorescence resonance energy transfer (FRET). Upon fusion and the attendant content mixing, the binding of biotin to streptavidin brings the Cy5 and phycoerythrin fluorophores into intimate contact, yielding a strong FRET signal (<xref ref-type="bibr" rid="bib47">Zucchi and Zick, 2011</xref>). Fusion incubations were performed with mixed Ypt7/R and Ypt7/3Q proteoliposomes and with external nonfluorescent streptavidin to block any signal from proteoliposome lysis. Each incubation had either HOPS or GST-PX to tether the membranes (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Also present from the start were either (a) buffer alone, (b) Sec17, (c) Sec18 and ATPγS, or (d) both Sec17 and Sec18/ATPγS. Fusion was monitored by FRET between the lumenal probes; the initial rate during the first 5 min is termed the α portion in <xref ref-type="fig" rid="fig1">Figure 1B–E</xref>. At 30 min, each reaction received a supplement of the components not added at time 0, that is, (a) Sec17, Sec18 and ATPγS, (b) Sec18 and ATPγS, (c) Sec17, or (d) buffer alone, so that all incubations had Sec17, Sec18, and ATPγS as the incubation continued in the β portion of the experiment (<xref ref-type="fig" rid="fig1">Figure 1B</xref> β-Eβ), from 30 to 32 min. Distinct information can be gleaned from the α and β intervals of the experiment, and these are considered in turn below.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Sec17, Sec18, and ATPγS promote rapid and homotypic fusion and vacuole protein sorting (HOPS)-independent fusion without SNARE zippering.</title><p>Proteoliposomes were prepared with vacuolar lipids, membrane-anchored Ypt7, and either R or the 3Q SNAREs with molar ratios of 1Ypt7:8000 lipids and 1 of each SNARE/16,000 lipids. Since Qc3Δ is a labile member of SNARE complexes (<xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>), a fivefold molar excess to the other SNAREs was used in preparing Ypt7/QaQbQc3Δ proteoliposomes. The initial mixtures at t = 0 were 18 μl, and remaining components were added at 30 min in 2 μl. Vertical dotted lines delineate the first 5 min, termed α, and the 2 min β interval after further additions.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73240-fig1-v2.tif"/></fig><sec id="s2-1"><title>HOPS is not required for Sec17/Sec18 stimulation of fusion</title><p>When the 3Q complex includes wild-type full-length Qc, HOPS-mediated fusion (<xref ref-type="fig" rid="fig1">Figure 1B</xref> α, black curve) shows only minor effects from adding either Sec17 (red), Sec18 with a nonhydrolyzable ATP analog (blue), or Sec17, Sec18, and ATPγS (green). In contrast, when the 3Q complex includes Qc3Δ to arrest SNARE zippering and block fusion (<xref ref-type="fig" rid="fig1">Figure 1C</xref> α, black curve), both Sec17 and Sec18 are required to bypass the zippering arrest and allow fusion (<xref ref-type="fig" rid="fig1">Figure 1C</xref> α, contrast the green curve vs. the blue, red or black curves).</p><p>The dimeric tether GST-PX (<xref ref-type="bibr" rid="bib30">Song and Wickner, 2019</xref>) also supports fusion with pre-assembled wild-type Q SNAREs (<xref ref-type="fig" rid="fig1">Figure 1D</xref> α, black curve), but this fusion is blocked by Sec17 (<xref ref-type="fig" rid="fig1">Figure 1D</xref> α, red curve) without rescue by Sec18 (green curve). When fusion with the dimeric GST-PX tether is blocked by the Qc3Δ mutation (<xref ref-type="fig" rid="fig1">Figure 1E</xref> α, black curve), there is no rescue by Sec17, alone or in combination with Sec18/ATPγS (<xref ref-type="fig" rid="fig1">Figure 1E</xref> α, red and green curves), since HOPS is the only tether which bypasses inhibition by Sec17 (<xref ref-type="bibr" rid="bib30">Song and Wickner, 2019</xref>).</p><p>At the end of these 30 min incubations, each reaction received a further addition of any components not added at time 0. After this addition, each incubation had Sec17, Sec18, and ATPγS. Fusion incubations continued in the β portion of the experiment, from 30 to 32 min, and beyond. Although full-length SNAREs support zippering and fusion with either the HOPS or GST-PX tether, a kinetic intermediate accumulates which gives some additional fusion upon addition of Sec17/Sec18/ATPγS (<xref ref-type="fig" rid="fig1">Figure 1</xref>, Bβ and Dβ, black curves). When SNARE zippering and the attendant fusion was blocked by the Qc3Δ mutation, HOPS-dependent zippering-bypass fusion requires Sec17, Sec18, and ATPγS (<xref ref-type="fig" rid="fig1">Figure 1C</xref> α), as reported (<xref ref-type="bibr" rid="bib31">Song et al., 2020</xref>; <xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>). In their absence, fusion intermediate accumulated, since there is rapid fusion upon their addition (<xref ref-type="fig" rid="fig1">Figure 1C</xref> β, curves a–c). Strikingly, though the presence of Sec17 from the start of the incubation blocks the formation of rapid-fusion intermediate with the GST-PX tether (<xref ref-type="fig" rid="fig1">Figure 1E</xref> β, red curve), rapid-fusion intermediate does accumulate with the GST-PX tether when Sec17 is absent, as Sec17 addition at 30 min triggers fusion (<xref ref-type="fig" rid="fig1">Figure 1E</xref> β, curves a and c). Replicates of this experiment were quantified for the fusion rate during the α and β intervals (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Inhibition by Sec17 with the GST-PX tether instead of HOPS is only seen when Sec17 is present from the start of the incubation, prior to <italic>trans</italic>-SNARE assembly (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, red curve b and green curve d), but once membranes have undergone tethering and <italic>trans</italic>-SNARE assembly, Sec17 and Sec18 support zippering-bypass fusion without HOPS (<xref ref-type="fig" rid="fig1">Figure 1E</xref> β, blue and black curves).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Sec17 may inhibit functional <italic>trans</italic>-SNARE complex assembly (<xref ref-type="bibr" rid="bib38">Wang et al., 2000</xref>) but, once zippering has begun, Sec17 associates with partially zippered SNAREs to directly promote fusion (<xref ref-type="bibr" rid="bib46">Zick et al., 2015</xref>; <xref ref-type="bibr" rid="bib9">Harner and Wickner, 2018</xref>; <xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>). Sec17 can block fusion of reconstituted proteoliposomes without HOPS (<xref ref-type="bibr" rid="bib18">Mima et al., 2008</xref>). HOPS engages each of the 4 SNAREs (<xref ref-type="bibr" rid="bib36">Stroupe et al., 2006</xref>; <xref ref-type="bibr" rid="bib1">Baker et al., 2015</xref>; <xref ref-type="bibr" rid="bib31">Song et al., 2020</xref>) and catalyzes their assembly (<xref ref-type="bibr" rid="bib1">Baker et al., 2015</xref>; <xref ref-type="bibr" rid="bib20">Orr et al., 2017</xref>; <xref ref-type="bibr" rid="bib12">Jiao et al., 2018</xref>; <xref ref-type="bibr" rid="bib31">Song et al., 2020</xref>) in a manner which renders fusion resistant to Sec17 (<xref ref-type="bibr" rid="bib18">Mima et al., 2008</xref>; <xref ref-type="bibr" rid="bib43">Xu et al., 2010</xref>; <xref ref-type="bibr" rid="bib30">Song and Wickner, 2019</xref>). Excessive Sec17 blocks the initial stages of fusion but stimulates fusion when added after <italic>trans</italic>-SNARE assembly (<xref ref-type="bibr" rid="bib46">Zick et al., 2015</xref>). With the synthetic tether GST-PX, Sec17 which interacts with SNAREs before they assemble into <italic>trans</italic>-complexes inhibits the subsequent fusion (<xref ref-type="bibr" rid="bib30">Song and Wickner, 2019</xref>). We now show that once fusion intermediates of <italic>trans</italic>-SNARE complexes have formed, Sec17 and Sec18 will promote zippering-bypass fusion whether tethering is by HOPS or by the synthetic tether GST-PX (<xref ref-type="fig" rid="fig1">Figure 1C</xref> β and Eβ). <xref ref-type="bibr" rid="bib24">Schwartz et al., 2017</xref>, found that polyethylene glycol (PEG) and SNARE induced tethering and fusion, arrested by Qc3Δ, could be restored by added Sec17. PEG not only tethers, but may enhance SNARE-mediated fusion (<xref ref-type="bibr" rid="bib45">Zick and Wickner, 2013</xref>) through promoting dehydration (<xref ref-type="bibr" rid="bib13">Lehtonen and Kinnunen, 1995</xref>) and protein association (<xref ref-type="bibr" rid="bib37">Wälchli et al., 2020</xref>) or, at high levels, induce fusion directly (<xref ref-type="bibr" rid="bib3">Burgess et al., 1992</xref>). Dimeric GST-PX only acts as a tether. Our findings complement those of <xref ref-type="bibr" rid="bib24">Schwartz et al., 2017</xref>, and show that a tether and partially zippered SNARE complex allow Sec17/Sec18 induction of fusion.</p><p>HOPS serves both as a tether (<xref ref-type="bibr" rid="bib10">Hickey and Wickner, 2010</xref>) and as a catalyst to initiate SNARE assembly (<xref ref-type="bibr" rid="bib1">Baker et al., 2015</xref>), but it has been unclear whether it catalyzes the later stages of zippering or is needed for Sec17/Sec18-induced fusion without zippering. The engagement of SNAREs by HOPS (<xref ref-type="bibr" rid="bib36">Stroupe et al., 2006</xref>; <xref ref-type="bibr" rid="bib1">Baker et al., 2015</xref>; <xref ref-type="bibr" rid="bib31">Song et al., 2020</xref>) largely bypasses Sec17 inhibition. Once SNAREs are partially zippered in trans, Sec17 and Sec18 do not need HOPS to support the completion of fusion. The completion of SNARE zippering is promoted by Sec17 (<xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>), and Sec17 displaces HOPS from SNARE complexes (<xref ref-type="bibr" rid="bib4">Collins et al., 2005</xref>; <xref ref-type="bibr" rid="bib24">Schwartz et al., 2017</xref>). The interactions among the SNAREs, Sec17/αSNAP, and Sec18/NSF are seen at a molecular level in the 20s complex, consisting of a 4-SNARE coiled coil anchored to membranes at their C-termini, surrounded by up to 4Sec17/αSNAP molecules, and all capped at the membrane-distal end by Sec18/NSF (<xref ref-type="bibr" rid="bib44">Zhao et al., 2015</xref>). A ‘<italic>trans</italic>-20s’ (<xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>; <xref ref-type="bibr" rid="bib22">Rizo et al., 2021</xref>) may generally drive fusion, since its elements are common to all exocytic and endocytic trafficking while the tethering complexes of other organelles are varied and often do not have the organelle’s SM protein as a tightly bound subunit like Vps33 is in HOPS (<xref ref-type="bibr" rid="bib2">Baker and Hughson, 2016</xref>). These findings support the model (<xref ref-type="bibr" rid="bib24">Schwartz et al., 2017</xref>; <xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>) that HOPS only acts for tethering and to catalyze the initial phase of zippering in a Sec17-resistant manner. HOPS is specific for fusion at the vacuole/lysosome, but Sec17/αSNAP, Sec18/NSF, and SNAREs are general elements of exocytic and endocytic vesicular trafficking. Our current findings suggest that Sec17 and Sec18 support of zippering-bypass fusion may not be restricted to the vacuole/lysosome, but may contribute to SNARE-mediated fusion at other steps in endocytic and exocytic vesicular trafficking. Testing this hypothesis will necessitate the reconstitution of fusion at other organelles with their SNAREs, Rab, Rab-effector tethering complex, and SM protein.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Nyv1</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000004083</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Vam3</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000005632</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Vti1</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000004810</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Vam7</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000003180</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Ypt7</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000004460</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Sec17</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000000146</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Sec18</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000000284</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Vps33</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000004388</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Vps39</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000002235</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Vps41</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000002487</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Vps16</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000005966</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Vps11</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000004844</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="bottom">Vps18</td><td align="left" valign="bottom"><italic>Saccharomyces</italic> Genome Database</td><td align="left" valign="bottom">SGD:S000004138</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">R (Nyv1)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21976702">21976702</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Purified from <italic>Escherichia coli</italic>.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Qa (Vam3)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18650938/">18650938</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Purified from <italic>Escherichia coli</italic>.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Qb (Vti1)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21976702">21976702</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Purified from <italic>Escherichia coli</italic>.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Qc (Vam7)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/17699614">17699614</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Purified from <italic>Escherichia coli</italic>.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Qc (Vam7) 3Δ</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19414611/">19414611</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Purified from <italic>Escherichia coli</italic>.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Ypt7-TM</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31235584/">31235584</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Purified from <italic>Escherichia coli</italic>.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Sec17</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19414611/">19414611</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Purified from <italic>Escherichia coli</italic>.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Sec18</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/8620540">8620540</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Purified from <italic>Escherichia coli</italic>.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">GST-PX</td><td align="left" valign="bottom">This Study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Purified from <italic>Escherichia coli</italic>.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">HOPS</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18385512">18385512</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Purified from <italic>Saccharomyces cerevisiae</italic></td></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">Cy5-derivatized streptavidin</td><td align="left" valign="bottom">SeraCare Life Sciences</td><td align="char" char="ndash" valign="bottom">5270–0023</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">Biotinylated PhycoE</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">p811</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">Streptavidin</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">434302</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">1,2-Dilinoleoyl-sn-glycero-3-phosphocholine</td><td align="left" valign="bottom">Avanti polar lipids</td><td align="char" char="." valign="bottom">850385</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">1,2-Dilinoleoyl-sn-glycero-3-phospho-L-serine</td><td align="left" valign="bottom">Avanti polar lipids</td><td align="char" char="." valign="bottom">840040</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">1,2-Dilinoleoyl-sn-glycero-3-phosphoethanolamine</td><td align="left" valign="bottom">Avanti polar lipids</td><td align="char" char="." valign="bottom">850755</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">1,2-Dilinoleoyl-sn-glycero-3-phosphate</td><td align="left" valign="bottom">Avanti polar lipids</td><td align="char" char="." valign="bottom">840885</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">L-α-Phosphatidylinositol</td><td align="left" valign="bottom">Avanti polar lipids</td><td align="char" char="." valign="bottom">840044</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">1,2-Dipalmitoyl-<italic>sn</italic>-glycerol</td><td align="left" valign="bottom">Avanti polar lipids</td><td align="char" char="." valign="bottom">800816</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">Ergosterol</td><td align="left" valign="bottom">Sigma</td><td align="char" char="." valign="bottom">45480</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">PI(3)P</td><td align="left" valign="bottom">Echelon Bioscience</td><td align="left" valign="bottom">P-3016</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">Rhodamine DHPE</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">L1392</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">NBD-PE</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">N360</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound,drug</td><td align="left" valign="bottom">Marina-blue</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">M12652</td><td align="left" valign="bottom"/></tr></tbody></table><table-wrap-foot><fn><p>Reagents were purchased, and proteins purified, as described in <xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>.</p></fn></table-wrap-foot></table-wrap><sec id="s4-1"><title>GST-PX constructions</title><p>DNA encoding the PX domain from the Qc SNARE Vam7 (amino acyl residues 2–123) was amplified by PCR with CloneAMP HiFi PCR premix (Takara Bio USA, Mountain View, CA). The amplified DNA fragment was cloned into BamHI and SalI digested pGST parallel1 vector (<xref ref-type="bibr" rid="bib26">Sheffield et al., 1999</xref>) with an NEBuilder HiFi DNA Assembly kit (NEB, Ipswich, MA).</p><p>For GST-PX:</p><p>F<named-content content-type="sequence"> AGGGCGCCATGGATCCGGCAGCTAATTCTGTAGGGAA.</named-content></p><p>R <named-content content-type="sequence">AGTTGAGCTCGTCGACTATGGCTTTGACAACTGCAGGA.</named-content></p><p>GST-PX was prepared as described (<xref ref-type="bibr" rid="bib6">Fratti and Wickner, 2007</xref>).</p><p>Proteoliposome preparation and fusion assays were as described in <xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>. In brief, proteoliposomes were separately preincubated for 10 min at 27°C with EDTA and GTP, followed by addition of MgCl<sub>2</sub>, to load the Ypt7 with GTP. After separate preincubation for 10 min at 27°C of both proteoliposome preparations and of mixtures of all soluble proteins (HOPS, GST-PX, Sec17, and Sec18/ATPγS) empty assay wells received in rapid succession 5 μl of Ypt7/R proteoliposomes, 5 μl of Ypt7/3Q proteoliposomes, and an 8 μl mixture of all soluble components. FRET representing fusion was recorded each minute for 30 min, as described (<xref ref-type="bibr" rid="bib32">Song et al., 2021</xref>), then the multiwell plate was withdrawn and 2 μl of buffer, Sec17, Sec18, or a mixture of Sec17, Sec18, and Mg:ATPγS were added and the plate returned to the machine in time for the 31 min time-point and those thereafter. Concentrations in the 20 μl final reactions were 50 nM HOPS, 1.4 μM GST-PX, 500 nM Sec17, 250 nM Sec18, and 1 mM ATPγS where present.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Visualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Funding acquisition, Resources, Supervision, Validation, Writing - original draft, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-73240-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Figure 1 - Source Data 1 contains the numerical data used to generate figure 1.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Amy Orr for expert technical assistance and Alex Merz for fruitful discussions. This work was supported by NIGMS grant R35GM118037.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>RW</given-names></name><name><surname>Jeffrey</surname><given-names>PD</given-names></name><name><surname>Zick</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>BP</given-names></name><name><surname>Wickner</surname><given-names>WT</given-names></name><name><surname>Hughson</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A direct role for the Sec1/Munc18-family protein Vps33 as a template for SNARE assembly</article-title><source>Science</source><volume>349</volume><fpage>1111</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1126/science.aac7906</pub-id><pub-id pub-id-type="pmid">26339030</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>RW</given-names></name><name><surname>Hughson</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Chaperoning SNARE assembly and disassembly</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>17</volume><fpage>465</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1038/nrm.2016.65</pub-id><pub-id pub-id-type="pmid">27301672</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>SW</given-names></name><name><surname>McIntosh</surname><given-names>TJ</given-names></name><name><surname>Lentz</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Modulation of Poly(ethylene glycol)-Induced fusion by membrane hydration: Importance of interbilayer separation</article-title><source>Biochemistry</source><volume>31</volume><fpage>2653</fpage><lpage>2661</lpage><pub-id pub-id-type="doi">10.1021/bi00125a004</pub-id><pub-id pub-id-type="pmid">1547208</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>KM</given-names></name><name><surname>Thorngren</surname><given-names>NL</given-names></name><name><surname>Fratti</surname><given-names>RA</given-names></name><name><surname>Wickner</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Sec17p and HOPS, in distinct SNARE complexes, mediate SNARE complex disruption or assembly for fusion</article-title><source>The EMBO Journal</source><volume>24</volume><fpage>1775</fpage><lpage>1786</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600658</pub-id><pub-id pub-id-type="pmid">15889152</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasshauer</surname><given-names>DK</given-names></name><name><surname>Sutton</surname><given-names>RB</given-names></name><name><surname>Brunger</surname><given-names>AT</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Conserved structural features of the synaptic fusion complex: SNARE proteins reclassified as Q- and R-SNAREs</article-title><source>PNAS</source><volume>95</volume><fpage>15781</fpage><lpage>15786</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.26.15781</pub-id><pub-id pub-id-type="pmid">9861047</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fratti</surname><given-names>RA</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Distinct targeting and fusion functions of the PX and SNARE domains of yeast vacuolar Vam7p</article-title><source>The Journal of Biological Chemistry</source><volume>282</volume><fpage>13133</fpage><lpage>13138</lpage><pub-id pub-id-type="doi">10.1074/jbc.M700584200</pub-id><pub-id pub-id-type="pmid">17347148</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>PI</given-names></name><name><surname>Otto</surname><given-names>H</given-names></name><name><surname>Barton</surname><given-names>N</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>The N-ethylmaleimide-sensitive fusion protein and alpha-SNAP induce a conformational change in syntaxin</article-title><source>The Journal of Biological Chemistry</source><volume>270</volume><fpage>16955</fpage><lpage>16961</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.28.16955</pub-id><pub-id pub-id-type="pmid">7622514</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>PI</given-names></name><name><surname>Roth</surname><given-names>R</given-names></name><name><surname>Morisaki</surname><given-names>H</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Heuser</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Structure and conformational changes in NSF and its membrane receptor complexes visualized by quick-freeze/deep-etch electron microscopy</article-title><source>Cell</source><volume>90</volume><fpage>523</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80512-7</pub-id><pub-id pub-id-type="pmid">9267032</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harner</surname><given-names>M</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Assembly of intermediates for rapid membrane fusion</article-title><source>The Journal of Biological Chemistry</source><volume>293</volume><fpage>1346</fpage><lpage>1352</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA117.000791</pub-id><pub-id pub-id-type="pmid">29208657</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickey</surname><given-names>CM</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>HOPS initiates vacuole docking by tethering membranes before trans-SNARE complex assembly</article-title><source>Molecular Biology of the Cell</source><volume>21</volume><fpage>2297</fpage><lpage>2305</lpage><pub-id pub-id-type="doi">10.1091/mbc.e10-01-0044</pub-id><pub-id pub-id-type="pmid">20462954</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Scheller</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>SNAREs--engines for membrane fusion</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>7</volume><fpage>631</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1038/nrm2002</pub-id><pub-id pub-id-type="pmid">16912714</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>M</given-names></name><name><surname>Port</surname><given-names>SA</given-names></name><name><surname>Baker</surname><given-names>RW</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Qu</surname><given-names>H</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Eisemann</surname><given-names>TJ</given-names></name><name><surname>Hughson</surname><given-names>FM</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Munc18-1 catalyzes neuronal SNARE assembly by templating SNARE association</article-title><source>eLife</source><volume>7</volume><elocation-id>e41771</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.41771</pub-id><pub-id pub-id-type="pmid">30540253</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehtonen</surname><given-names>JY</given-names></name><name><surname>Kinnunen</surname><given-names>PK</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Poly(ethylene glycol)-induced and temperature-dependent phase separation in fluid binary phospholipid membranes</article-title><source>Biophysical Journal</source><volume>68</volume><fpage>525</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(95)80214-6</pub-id><pub-id pub-id-type="pmid">7696506</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobingier</surname><given-names>BT</given-names></name><name><surname>Nickerson</surname><given-names>DP</given-names></name><name><surname>Lo</surname><given-names>SY</given-names></name><name><surname>Merz</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>SM proteins Sly1 and Vps33 co-assemble with Sec17 and SNARE complexes to oppose SNARE disassembly by Sec18</article-title><source>eLife</source><volume>3</volume><elocation-id>e02272</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.02272</pub-id><pub-id pub-id-type="pmid">24837546</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Jiao</surname><given-names>J</given-names></name><name><surname>Rebane</surname><given-names>AA</given-names></name><name><surname>Cha</surname><given-names>HK</given-names></name><name><surname>Xi</surname><given-names>Z</given-names></name><name><surname>Qu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>α-SNAP enhances SNARE zippering by stabilizing the SNARE Four-Helix bundle</article-title><source>Cell Reports</source><volume>15</volume><fpage>531</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.03.050</pub-id><pub-id pub-id-type="pmid">27068468</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>V</given-names></name><name><surname>Orci</surname><given-names>L</given-names></name><name><surname>Glick</surname><given-names>BS</given-names></name><name><surname>Block</surname><given-names>MR</given-names></name><name><surname>Rothman</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Role of an N-ethylmaleimide-sensitive transport component in promoting fusion of transport vesicles with cisternae of the Golgi stack</article-title><source>Cell</source><volume>54</volume><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(88)90554-5</pub-id><pub-id pub-id-type="pmid">3390865</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>A</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name><name><surname>Haas</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Sec18p (NSF)-driven release of Sec17p (alpha-SNAP) can precede docking and fusion of yeast vacuoles</article-title><source>Cell</source><volume>85</volume><fpage>83</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81084-3</pub-id><pub-id pub-id-type="pmid">8620540</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mima</surname><given-names>J</given-names></name><name><surname>Hickey</surname><given-names>CM</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Jun</surname><given-names>Y</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Reconstituted membrane fusion requires regulatory lipids, SNAREs and synergistic SNARE chaperones</article-title><source>The EMBO Journal</source><volume>27</volume><fpage>2031</fpage><lpage>2042</lpage><pub-id pub-id-type="doi">10.1038/emboj.2008.139</pub-id><pub-id pub-id-type="pmid">18650938</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orr</surname><given-names>A</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name><name><surname>Rusin</surname><given-names>SF</given-names></name><name><surname>Kettenbach</surname><given-names>AN</given-names></name><name><surname>Zick</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Yeast vacuolar HOPS, regulated by its kinase, exploits affinities for acidic lipids and Rab:GTP for membrane binding and to catalyze tethering and fusion</article-title><source>Molecular Biology of the Cell</source><volume>26</volume><fpage>305</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1091/mbc.E14-08-1298</pub-id><pub-id pub-id-type="pmid">25411340</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orr</surname><given-names>A</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Rusin</surname><given-names>SF</given-names></name><name><surname>Kettenbach</surname><given-names>AN</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>HOPS catalyzes the interdependent assembly of each vacuolar SNARE into a SNARE complex</article-title><source>Molecular Biology of the Cell</source><volume>28</volume><fpage>975</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1091/mbc.E16-10-0743</pub-id><pub-id pub-id-type="pmid">28148647</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prinslow</surname><given-names>EA</given-names></name><name><surname>Stepien</surname><given-names>KP</given-names></name><name><surname>Pan</surname><given-names>YZ</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multiple factors maintain assembled trans-SNARE complexes in the presence of NSF and αSNAP</article-title><source>eLife</source><volume>8</volume><elocation-id>e38880</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.38880</pub-id><pub-id pub-id-type="pmid">30657450</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizo</surname><given-names>J</given-names></name><name><surname>Jaczynska</surname><given-names>K</given-names></name><name><surname>Stepien</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Molecular machinery turns full circle</article-title><source>eLife</source><volume>10</volume><elocation-id>e70298</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.70298</pub-id><pub-id pub-id-type="pmid">34137372</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>M.L</given-names></name><name><surname>Merz</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Capture and release of partially zipped trans-SNARE complexes on intact organelles</article-title><source>The Journal of Cell Biology</source><volume>185</volume><fpage>535</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1083/jcb.200811082</pub-id><pub-id pub-id-type="pmid">19414611</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>ML</given-names></name><name><surname>Nickerson</surname><given-names>DP</given-names></name><name><surname>Lobingier</surname><given-names>BT</given-names></name><name><surname>Plemel</surname><given-names>RL</given-names></name><name><surname>Duan</surname><given-names>M</given-names></name><name><surname>Angers</surname><given-names>CG</given-names></name><name><surname>Zick</surname><given-names>M</given-names></name><name><surname>Merz</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sec17 (α-SNAP) and an SM-tethering complex regulate the outcome of SNARE zippering in vitro and in vivo</article-title><source>eLife</source><volume>6</volume><elocation-id>e27396</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.27396</pub-id><pub-id pub-id-type="pmid">28925353</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seals</surname><given-names>DF</given-names></name><name><surname>Eitzen</surname><given-names>G</given-names></name><name><surname>Margolis</surname><given-names>N</given-names></name><name><surname>Wickner</surname><given-names>WT</given-names></name><name><surname>Price</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A Ypt/Rab effector complex containing the Sec1 homolog Vps33p is required for homotypic vacuole fusion</article-title><source>PNAS</source><volume>97</volume><fpage>9402</fpage><lpage>9407</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.17.9402</pub-id><pub-id pub-id-type="pmid">10944212</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheffield</surname><given-names>P</given-names></name><name><surname>Garrard</surname><given-names>S</given-names></name><name><surname>Derewenda</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Overcoming Expression and Purification Problems of RhoGDI Using a Family of “Parallel” Expression Vectors</article-title><source>Protein Expression and Purification</source><volume>15</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1006/prep.1998.1003</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Söllner</surname><given-names>T</given-names></name><name><surname>Bennett</surname><given-names>MK</given-names></name><name><surname>Whiteheart</surname><given-names>SW</given-names></name><name><surname>Scheller</surname><given-names>RH</given-names></name><name><surname>Rothman</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="1993">1993a</year><article-title>A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion</article-title><source>Cell</source><volume>75</volume><fpage>409</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90376-2</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Söllner</surname><given-names>T</given-names></name><name><surname>Whiteheart</surname><given-names>SW</given-names></name><name><surname>Brunner</surname><given-names>M</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name><surname>Geromanos</surname><given-names>S</given-names></name><name><surname>Tempst</surname><given-names>P</given-names></name><name><surname>Rothman</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="1993">1993b</year><article-title>SNAP receptors implicated in vesicle targeting and fusion</article-title><source>Nature</source><volume>362</volume><fpage>318</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1038/362318a0</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Orr</surname><given-names>A</given-names></name><name><surname>Duan</surname><given-names>M</given-names></name><name><surname>Merz</surname><given-names>AJ</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sec17/Sec18 act twice, enhancing membrane fusion and then disassembling cis-SNARE complexes</article-title><source>eLife</source><volume>6</volume><elocation-id>e26646</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.26646</pub-id><pub-id pub-id-type="pmid">28718762</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Tethering guides fusion-competent trans-SNARE assembly</article-title><source>PNAS</source><volume>116</volume><fpage>13952</fpage><lpage>13957</lpage><pub-id pub-id-type="doi">10.1073/pnas.1907640116</pub-id><pub-id pub-id-type="pmid">31235584</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Orr</surname><given-names>AS</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Harner</surname><given-names>ME</given-names></name><name><surname>Wickner</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>HOPS recognizes each SNARE, assembling ternary trans-complexes for rapid fusion upon engagement with the 4th SNARE</article-title><source>eLife</source><volume>9</volume><elocation-id>e53559</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.53559</pub-id><pub-id pub-id-type="pmid">31961324</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Torng</surname><given-names>TL</given-names></name><name><surname>Orr</surname><given-names>AS</given-names></name><name><surname>Brunger</surname><given-names>AT</given-names></name><name><surname>Wickner</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Sec17/Sec18 can support membrane fusion without help from completion of SNARE zippering</article-title><source>eLife</source><volume>10</volume><elocation-id>e67578</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.67578</pub-id><pub-id pub-id-type="pmid">33944780</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sørensen</surname><given-names>JB</given-names></name><name><surname>Wiederhold</surname><given-names>K</given-names></name><name><surname>Müller</surname><given-names>EM</given-names></name><name><surname>Milosevic</surname><given-names>I</given-names></name><name><surname>Nagy</surname><given-names>G</given-names></name><name><surname>De Groot</surname><given-names>BL</given-names></name><name><surname>Grubmüller</surname><given-names>H</given-names></name><name><surname>Fasshauer</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Sequential N- to C-terminal SNARE complex assembly drives priming and fusion of secretory vesicles</article-title><source>The EMBO Journal</source><volume>25</volume><fpage>955</fpage><lpage>966</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601003</pub-id><pub-id pub-id-type="pmid">16498411</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torng</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Asymmetric Rab activation of vacuolar HOPS to catalyze SNARE complex assembly</article-title><source>Molecular Biology of the Cell</source><volume>31</volume><fpage>1060</fpage><lpage>1068</lpage><pub-id pub-id-type="doi">10.1091/mbc.E20-01-0019</pub-id><pub-id pub-id-type="pmid">32160129</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stepien</surname><given-names>KP</given-names></name><name><surname>Prinslow</surname><given-names>EA</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Munc18-1 is crucial to overcome the inhibition of synaptic vesicle fusion by αSNAP</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>4326</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-12188-4</pub-id><pub-id pub-id-type="pmid">31548544</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stroupe</surname><given-names>C</given-names></name><name><surname>Collins</surname><given-names>KM</given-names></name><name><surname>Fratti</surname><given-names>RA</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Purification of active HOPS complex reveals its affinities for phosphoinositides and the SNARE Vam7p</article-title><source>The EMBO Journal</source><volume>25</volume><fpage>1579</fpage><lpage>1589</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601051</pub-id><pub-id pub-id-type="pmid">16601699</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wälchli</surname><given-names>R</given-names></name><name><surname>Fanizzi</surname><given-names>F</given-names></name><name><surname>Massant</surname><given-names>J</given-names></name><name><surname>Arosio</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Relationship of PEG-induced precipitation with protein-protein interactions and aggregation rates of high concentration mAb formulations at 5 °C</article-title><source>European Journal of Pharmaceutics and Biopharmaceutics</source><volume>151</volume><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2020.03.011</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Ungermann</surname><given-names>C</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The docking of primed vacuoles can be reversibly arrested by excess Sec17p (alpha-SNAP)</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>22862</fpage><lpage>22867</lpage><pub-id pub-id-type="doi">10.1074/jbc.M001447200</pub-id><pub-id pub-id-type="pmid">10816559</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>T</given-names></name><name><surname>Zemelman</surname><given-names>BV</given-names></name><name><surname>McNew</surname><given-names>JA</given-names></name><name><surname>Westermann</surname><given-names>B</given-names></name><name><surname>Gmachl</surname><given-names>M</given-names></name><name><surname>Parlati</surname><given-names>F</given-names></name><name><surname>Söllner</surname><given-names>TH</given-names></name><name><surname>Rothman</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>SNAREpins: minimal machinery for membrane fusion</article-title><source>Cell</source><volume>92</volume><fpage>759</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81404-x</pub-id><pub-id pub-id-type="pmid">9529252</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whiteheart</surname><given-names>SW</given-names></name><name><surname>Brunner</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>DW</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><name><surname>Rothman</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Soluble N-ethylmaleimide-sensitive fusion attachment proteins (SNAPs) bind to a multi-SNAP receptor complex in Golgi membranes</article-title><source>The Journal of Biological Chemistry</source><volume>267</volume><fpage>12239</fpage><lpage>12243</lpage><pub-id pub-id-type="pmid">1601890</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickner</surname><given-names>W</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A cascade of multiple proteins and lipids catalyzes membrane fusion</article-title><source>Molecular Biology of the Cell</source><volume>28</volume><fpage>707</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1091/mbc.E16-07-0517</pub-id><pub-id pub-id-type="pmid">28292915</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wurmser</surname><given-names>AE</given-names></name><name><surname>Sato</surname><given-names>TK</given-names></name><name><surname>Emr</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>New Component of the vacuolar class C-Vps complex couples nucleotide exchange on the Ypt7 GTPase to SNARE-dependent docking and fusion</article-title><source>The Journal of Cell Biology</source><volume>151</volume><fpage>551</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1083/jcb.151.3.551</pub-id><pub-id pub-id-type="pmid">11062257</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Jun</surname><given-names>Y</given-names></name><name><surname>Thompson</surname><given-names>J</given-names></name><name><surname>Yates</surname><given-names>J</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>HOPS prevents the disassembly of trans-SNARE complexes by Sec17p/Sec18p during membrane fusion</article-title><source>The EMBO Journal</source><volume>29</volume><fpage>1948</fpage><lpage>1960</lpage><pub-id pub-id-type="doi">10.1038/emboj.2010.97</pub-id><pub-id pub-id-type="pmid">20473271</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Vivona</surname><given-names>S</given-names></name><name><surname>Cipriano</surname><given-names>DJ</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Brunger</surname><given-names>AT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mechanistic insights into the recycling machine of the SNARE complex</article-title><source>Nature</source><volume>518</volume><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1038/nature14148</pub-id><pub-id pub-id-type="pmid">25581794</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zick</surname><given-names>M</given-names></name><name><surname>Wickner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The tethering complex HOPS catalyzes assembly of the soluble SNARE Vam7 into fusogenic trans-SNARE complexes</article-title><source>Molecular Biology of the Cell</source><volume>24</volume><fpage>3746</fpage><lpage>3753</lpage><pub-id pub-id-type="doi">10.1091/mbc.e13-07-0419</pub-id><pub-id pub-id-type="pmid">24088569</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zick</surname><given-names>M</given-names></name><name><surname>Orr</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>ML</given-names></name><name><surname>Merz</surname><given-names>AJ</given-names></name><name><surname>Wickner</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sec17 can trigger fusion of trans -SNARE paired membranes without Sec18</article-title><source>PNAS</source><volume>112</volume><fpage>E2290</fpage><lpage>E2297</lpage><pub-id pub-id-type="doi">10.1073/pnas.1506409112</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zucchi</surname><given-names>PC</given-names></name><name><surname>Zick</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Membrane fusion catalyzed by a Rab, SNAREs, and SNARE chaperones is accompanied by enhanced permeability to small molecules and by lysis</article-title><source>Molecular Biology of the Cell</source><volume>22</volume><fpage>4635</fpage><lpage>4646</lpage><pub-id pub-id-type="doi">10.1091/mbc.E11-08-0680</pub-id><pub-id pub-id-type="pmid">21976702</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73240.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Linstedt</surname><given-names>Adam</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Carnegie Mellon University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>This Research Advance answers an important question arising from the author's previous paper on in vitro vacuole fusion: whether the tether HOPS is needed for an unexpected direct role played by Sec17 and Sec18 in facilitating SNARE zippering and thus membrane fusion. An artificial tether substitutes for HOPS, so HOPS is not specifically needed. Therefore, this unexpected role for Sec17/18 could extend to other SNARE-mediated fusion reactions.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73240.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Linstedt</surname><given-names>Adam</given-names></name><role>Reviewing Editor</role><aff><institution>Carnegie Mellon University</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Merz</surname><given-names>Alexey J</given-names></name><role>Reviewer</role><aff><institution>University of Washington School of Medicine</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>[Editors’ note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.]</p><p>Thank you for submitting the paper &quot;Membrane Fusion can be Driven by Sec18/NSF, Sec17/αSNAP, and <italic>trans</italic>-SNARE complex without HOPS&quot; for consideration at <italic>eLife</italic>. Your initial submission has been assessed by a Senior Editor in consultation with expert members of the Board of Reviewing Editors. Although the work is of interest, we regret to inform you that the findings at this stage are too preliminary for further consideration at <italic>eLife</italic>.</p><p>Expert #1. &quot;…As a &quot;research advance&quot; the work does answer an important question left by their previous <italic>eLife</italic> paper: whether HOPS is needed for Sec17 and Sec18 to engage partially zippered SNAREs. An artificial tether substitutes so HOPS is not specifically needed and this unexpected role for Sec17/18 could extend to other fusion reactions. It is careful biochemistry that extends an e<italic>Life</italic> paper and provides data supporting a (controversial) direct role for Sec17/18 in content mixing. However, in its present form, the work doesn't go far enough to address whether the proposed novel role for Sec17/18 occurs and makes an important contribution to the reaction under normal conditions.&quot;</p><p>Expert #2. &quot;Here the authors rely on an artificial truncation of one of the SNAREs, as in the previous paper, and eliminate HOPS in favor of an artificial tether. This creates a situation in which Sec17 and 18 appear to be essential for fusion. How specific is the requirement for Sec17 and 18 when their natural binding partners are altered? For this study to be meaningful, the authors would have to show that the pair of native proteins are required for fusion per se under more normal conditions with the full set of SNAREs, HOPS etc.&quot;</p><p>[Editors’ note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for submitting your article &quot;Fusion of Tethered Membranes can be Driven by Sec18/NSF and Sec17/αSNAP without HOPS&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Suzanne Pfeffer as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Alexey J Merz (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>This brief study has now been reviewed by three experts. There was only one technical issue raised (titration of components). However, all three reviewers were concerned about the &quot;incremental&quot; nature of the advance. The study shows that their Sec17/18-dependent vacuole fusion reaction employing arrested SNAREs and without ATP hydrolysis proceeds without a specific contribution from HOPS. The potential significance of this to a wider audience is that Sec17/18 may contribute directly to the fusion step of many or all SNARE-mediated fusion reactions. But this aspect is not sufficiently tested and needs to be addressed. This and the other reviewer issues are compiled below. Feasibility is clearly a concern regarding an in vivo test (point#4) but the issue of evidence that it normally occurs (e.g. rate acceleration for wildtype components as in point#1) merits particular attention.</p><p>1. A main issue is the increment of advance. It succeeds in filling in a missing piece of their 2021 paper but on its own does not substantially advance understanding of the critical issue of whether Sec17/18 normally plays this role. If it did, one would expect fusion by normal SNAREs to be significantly accelerated by Sec17/18. From Figure 1B, 1F, this does not appear to be the case.</p><p>2. One would expect Sec17/18 association with the normal SNAREs to occur prior to fusion, but there is no data to address this.</p><p>3. The concentration of Sec17/18, the most critical component, is not indicated in either the figure legend or methods.</p><p>4. Can this unexpected role for Sec17/18 be demonstrated/confirmed for intact cells? Is it essential for wildtype rates of fusion? Or is it strictly redundant in the face of the assembly force of SNARE pairing as a driving force for fusion?</p><p>5. Does it actually act on other SNAREs? This is important because the clearest argument for this brief study being viewed as a highly significant research advance (over their previous work) is the implication that the unexpected direct role of Sec17/18 can now be considered likely to take place in other, if not all, SNARE-mediated fusion events.</p><p>6. No concentrations for any soluble component are given. The final concentrations of Vam7/Qc, Sec17, Sec18, HOPS, ATPgS, etc., must be specified. Readers should not have to look at prior publications to locate this information. A possible criticism of this and some similar prior work is that the experiments are conducted at only single concentrations of each reagent, rather than using concentration titrations for the protein components in the reaction. Nevertheless, the results support the authors' conclusions and are broadly consistent with prior work.</p><p>7. The last paragraph of the introduction could probably be omitted without loss of clarity.</p><p>8. Line 46: extensive mutational analyses (both in vitro and in vivo) of the Sec17 membrane-interaction loop is present in Schwartz et al. 2017. This work should be cited.</p><p>9. Lines 62-65: the pioneering paper by Hanson, Jahn et al. was a key step toward the consensus that SNARE complexes are oriented in a parallel coiled coil, and that Sec17/18 may act after, rather than before, fusion. It should be cited.</p><p>10. Lines 72-73: again, Schwartz et al., 2017 should be cited.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73240.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>[Editors’ note: the authors resubmitted a revised version of the paper for consideration. What follows is the authors’ response to the first round of review.]</p><disp-quote content-type="editor-comment"><p>Expert #1. &quot;…As a &quot;research advance&quot; the work does answer an important question left by their previous eLife paper: whether HOPS is needed for Sec17 and Sec18 to engage partially zippered SNAREs. An artificial tether substitutes so HOPS is not specifically needed and this unexpected role for Sec17/18 could extend to other fusion reactions. It is careful biochemistry that extends an eLife paper and provides data supporting a (controversial) direct role for Sec17/18 in content mixing. However, in its present form, the work doesn't go far enough to address whether the proposed novel role for Sec17/18 occurs and makes an important contribution to the reaction under normal conditions.&quot;</p><p>Expert #2. &quot;Here the authors rely on an artificial truncation of one of the SNAREs, as in the previous paper, and eliminate HOPS in favor of an artificial tether. This creates a situation in which Sec17 and 18 appear to be essential for fusion. How specific is the requirement for Sec17 and 18 when their natural binding partners are altered? For this study to be meaningful, the authors would have to show that the pair of native proteins are required for fusion per se under more normal conditions with the full set of SNAREs, HOPS etc.&quot;</p></disp-quote><p>We now state clearly, with reference, that Sec17/Sec18 stimulation has been reported with all wild-type components, i.e., SNAREs. Our new finding establishes that the role of Sec17/Sec18 in promoting fusion is not limited to HOPS-catalyzed reactions, and thus merits serious considerations for other endocytic and exocytic trafficking steps</p><p>[Editors’ note: what follows is the authors’ response to the second round of review.]</p><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>This brief study has now been reviewed by three experts. There was only one technical issue raised (titration of components). However, all three reviewers were concerned about the &quot;incremental&quot; nature of the advance. The study shows that their Sec17/18-dependent vacuole fusion reaction employing arrested SNAREs and without ATP hydrolysis proceeds without a specific contribution from HOPS. The potential significance of this to a wider audience is that Sec17/18 may contribute directly to the fusion step of many or all SNARE-mediated fusion reactions. But this aspect is not sufficiently tested and needs to be addressed. This and the other reviewer issues are compiled below. Feasibility is clearly a concern regarding an in vivo test (point#4) but the issue of evidence that it normally occurs (e.g. rate acceleration for wildtype components as in point#1) merits particular attention.</p><p>1. A main issue is the increment of advance. It succeeds in filling in a missing piece of their 2021 paper but on its own does not substantially advance understanding of the critical issue of whether Sec17/18 normally plays this role. If it did, one would expect fusion by normal SNAREs to be significantly accelerated by Sec17/18. From Figure 1B, 1F, this does not appear to be the case.</p></disp-quote><p>This point is now directly addressed in the next-to-last paragraph of the Introduction:</p><p>&quot;Sec17 and Sec18 enhance the rate of HOPS-dependent vacuole membrane fusion with all wild-type fusion components (Mima, 2008, Zick et al., 2015; Song et al., 2017; Schwartz et al., 2017) without requiring ATP hydrolysis (Zick et al., 2015; Song et al., 2017). […] Our current work, substituting a synthetic protein tether for HOPS, shows that Sec17/Sec18 can also drive HOPS-independent fusion.&quot;</p><p>A similar analysis in non-vacuolar fusion reactions will require their reconstitution with all purified components, not only SNAREs, NSF, and SNAP but also SM protiens, tethering complexes, Rabs, and other factors. This is nearly achieved now for synaptic fusion, but the multiple proteins special to the Ca-responsivity of the synapse (synaptotagmin, Munc13, Complexin) distinguish its fusion from that of general endocytic and exocytic traffic. Endosome homotypic fusion was brilliantly reconstituted by Zerial and colleagues in a Nature study, but there has been no follow-through of mechanistic studies in the ensuing years. Thus other systems to test the generality of our findings with vacuolar fusion are still lacking.</p><disp-quote content-type="editor-comment"><p>2. One would expect Sec17/18 association with the normal SNAREs to occur prior to fusion, but there is no data to address this.</p></disp-quote><p>This was addressed most directly in Harner and Wickner (2018), and we've added this at the start of the Discussion in the revised paper.</p><disp-quote content-type="editor-comment"><p>3. The concentration of Sec17/18, the most critical component, is not indicated in either the figure legend or methods.</p></disp-quote><p>Sorry for this awful omission. We've now added these concentrations to the figure legend: 500nM Sec17, 250nM Sec18, and 1mM ATPgS.</p><disp-quote content-type="editor-comment"><p>4. Can this unexpected role for Sec17/18 be demonstrated/confirmed for intact cells? Is it essential for wildtype rates of fusion? Or is it strictly redundant in the face of the assembly force of SNARE pairing as a driving force for fusion?</p></disp-quote><p>We now cite this more clearly in the introduction: &quot;Rapid HOPS-dependent fusion requires both SNARE zippering and Sec17 with its apolar loops, as analyzed in vitro and in vivo, where overexpression of Sec17 with an intact N-terminal apolar loop substantially restored the fusion defect caused by Qc-SNARE domain truncation (Schwartz et al., 2017).&quot; Is it essential for wildtype rates of fusion? Or is it strictly redundant in the face of the assembly force of SNARE pairing as a driving force for fusion? I'm not sure how we'd measure the wild-type (in vivo) rate of fusion, but we certainly haven't in the past. I'm a bit unclear about just what's being asked here. Zippering and Sec17-induced fusion are redundant, but (perhaps more important) they're complementary. The Song et al. 2021 <italic>eLife</italic> paper, which the current submission is built upon, shows that &quot; Slow fusion can be driven either by zippering or by the apolar loops of Sec17 which had assembled on a platform of at least partially zippered <italic>trans</italic>-SNARE complex, but rapid HOPS-dependent fusion requires both SNARE zippering and Sec17 with its apolar loops.&quot; (as stated in the current Introduction).</p><disp-quote content-type="editor-comment"><p>5. Does it actually act on other SNAREs? This is important because the clearest argument for this brief study being viewed as a highly significant research advance (over their previous work) is the implication that the unexpected direct role of Sec17/18 can now be considered likely to take place in other, if not all, SNARE-mediated fusion events.</p></disp-quote><p>We now address this important question directly at the end of the Discussion: &quot;Our current findings suggest that Sec17 and Sec18 support of zippering-bypass fusion may not be restricted to the vacuole/lysosome, but may contribute to SNARE-mediated fusion at other steps in endocytic and exocytic vesicular trafficking. Testing this hypothesis will necessitate the reconstitution of fusion at other organelles with their SNAREs, Rab, Rab-effector tethering complex, and SM protein.&quot; This is far beyond our current scope.</p><disp-quote content-type="editor-comment"><p>6. No concentrations for any soluble component are given. The final concentrations of Vam7/Qc, Sec17, Sec18, HOPS, ATPgS, etc., must be specified. Readers should not have to look at prior publications to locate this information. A possible criticism of this and some similar prior work is that the experiments are conducted at only single concentrations of each reagent, rather than using concentration titrations for the protein components in the reaction. Nevertheless, the results support the authors' conclusions and are broadly consistent with prior work.</p></disp-quote><p>I apologize for this awful omission. These concentrations are now explicit in the last paragraph of the Methods. All the assays are with 3Q-proteoliposome, and thus there is no concentration given for Qc (which isn't added per se, it's part of the 3Q).</p><disp-quote content-type="editor-comment"><p>7. The last paragraph of the introduction could probably be omitted without loss of clarity.</p></disp-quote><p>We have rearranged, and rewritten, the Introduction with a goal of added clarity. We beg to be allowed to keep the last paragraph, as we feel it provides a useful overview of the strategy we've followed.</p><disp-quote content-type="editor-comment"><p>8. Line 46: extensive mutational analyses (both in vitro and in vivo) of the Sec17 membrane-interaction loop is present in Schwartz et al. 2017. This work should be cited.</p></disp-quote><p>Thank you, we do now.</p><disp-quote content-type="editor-comment"><p>9. Lines 62-65: the pioneering paper by Hanson, Jahn et al. was a key step toward the consensus that SNARE complexes are oriented in a parallel coiled coil, and that Sec17/18 may act after, rather than before, fusion. It should be cited.</p></disp-quote><p>Thank you, we've added two citations to their pioneering work.</p><disp-quote content-type="editor-comment"><p>10. Lines 72-73: again, Schwartz et al., 2017 should be cited.</p></disp-quote><p>Thank you, now done.</p></body></sub-article></article>